Minimal contribution of desmethyl-gefitinib, the major human plasma metabolite of gefitinib, to epidermal growth factor receptor (EGFR)-mediated tumour growth inhibition

詳細情報 詳細情報について

• CRID

  1362262944514197248

• DOI

  10.1080/00498250500523253

• ISSN

  13665928

  00498254

• Web Site

  http://www.tandfonline.com/doi/pdf/10.1080/00498250500523253

• データソース種別

  • Crossref